Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSGeneric

TRIFERIC

FERRIC PYROPHOSPHATE CITRATE

Standard Dose
272MG IRON/PACKET
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TRIFERIC is listed in Drugs@FDA under application 208551 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient FERRIC PYROPHOSPHATE CITRATE Form and strength POWDER;INTRAVENOUS - 272MG IRON/PACKET Sponsor ROCKWELL MEDICAL INC Submission history Latest submission status date: 2018-03-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRIFERIC is listed in Drugs@FDA under application 208551 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient FERRIC PYROPHOSPHATE CITRATE Form and strength POWDER;INTRAVENOUS - 272MG IRON/PACKET Sponsor ROCKWELL MEDICAL INC Submission history Latest submission status date: 2018-03-29 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.